This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
A team of healthcare scholars is making U.S. states an offer they hope the border-defined polities won’t refuse: If you’ll pay for the reinvention of primary care, we’ll help sell the public on the rightness of measured, state-level efforts to preserve the profession.
Teladoc, the popular telehealth platform, will provide urgent care, dermatology and nutrition support through Walmart’s existing virtual patient care platform. The companies made the announcement Thursday.
As a class-action lawsuit gets rolling in California over the use of ambient AI in healthcare, a national law firm is drawing takeaways for hospitals and other provider organizations. Makes sense: All AI-equipped providers are potential targets for similar litigation now.
The ankle-brachial index, a noninvasive diagnostic test for peripheral artery disease, may provide even more value than clinicians previously realized.
HHS’s 340B drug discount program is set to shift to a rebate model on New Year’s Day. But a lawsuit and temporary restraining order filed by the AHA and others may block the change from going live on time.
Will there or won’t there be a federal moratorium on state-level regulation of AI?That’s only one question healthcare stakeholders are asking as 2025’s time begins running out.
Advanced AI technologies are starting to play a bigger role in TAVR care, helping cardiologists plan ahead, make critical decisions and predict potential complications. Looking to the future, though, it is clear this is just the beginning.
Hospitals could be turning away high-risk heart patients to help their TAVR programs receive a higher ranking, according to new research published in JACC: Cardiovascular Interventions.
Some cardiologists feel the specialty is inclusive and nothing needs to change, but not everyone agrees with that sentiment. A new survey detailed the perspective of more than 1,500 cardiologists.
The recall was put in place after a hydrophilic coating was discovered on the inside of the devices. According to the FDA, patients treated with the catheters could face a number of significant risks.